Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (463)

Latest Posts

About This Stock More About This Stock
Oracle Wins TikTok Bid, Nvidia Buys Arm For $40bn
Article By: Adam Vettese
Monday, September 14, 2020 6:00 AM EDT
The weekend was packed with M&A news, with three deals all likely to be well north of $10bn apiece reported. First up, Oracle has reportedly won the bidding to buy TikTok’s US operations, with the Microsoft-Walmart joint offer being rejected.
In this article: APA, CVX, IAG, LEN, OXY, WMT, XOM, AIVAF, GLCNF, IMMU, AAPL, ARMH, GILD, INTC, MSFT, NVDA, ORCL, DIA, FXB, SPY, COMP, SPX, BITCOMP, NGLOY, ETH-X, JDDSF, RTPPF, SFTBY
Read
Gilead To Explore Trodelvy Drug Against Different Cancers After $21B Merger With Immunomedics
Article By: Benzinga
Monday, September 14, 2020 4:50 AM EDT
After initial reports emerged on Saturday about a potential acquisition deal, Gilead Sciences Inc. confirmed that it's set to purchase Immunomedics Inc. 
In this article: IMMU, GILD
Read
Gilead Sciences To Acquire Immunomedics
Article By: Business Wire
Sunday, September 13, 2020 3:51 PM EDT
Gilead Sciences, Inc. and Immunomedics announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for $88.00 per share. The transaction values Immunomedics at approximately $21 billion.
In this article: IMMU, GILD Also: KITE
Read
Gilead Sciences And Cancer Treatment Company Immunomedics In $20B Deal
Article By: Benzinga
Sunday, September 13, 2020 5:49 AM EDT
Gilead Sciences Inc. is gearing up to purchase drug innovator Immunomedics Inc. for a price tag exceeding $20 billion.
In this article: IMMU, GILD
Read
Stocks Are Heading Lower On September 10 Ahead Of The ECB
Article By: Michael J. Kramer
Thursday, September 10, 2020 7:16 AM EDT
Stocks are trading lower this morning ahead of the ECB rate announcement.
In this article: REGN, GILD, VRTX, SPY
Read

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments